These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Pleurisy caused by Mycobacterium flavescens]. de Escalante B; Lacasa J; Ruiz F; Sánchez E Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):169. PubMed ID: 8011727 [No Abstract] [Full Text] [Related]
24. [Resistance of strains of atypical mycobacteria to chemo-antibiotics, with special attention to the so-called minor antitubercular drugs]. Vercellino E G Mal Infett Parassit; 1968 Feb; 20(2):195-6. PubMed ID: 5741087 [No Abstract] [Full Text] [Related]
29. Atypical mycobacteria in a tuberculosis hospital. Gale GL Can Med Assoc J; 1976 Apr; 114(7):612-4. PubMed ID: 1260602 [TBL] [Abstract][Full Text] [Related]
30. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics]. Sakurai N Kekkaku; 1983 Jun; 58(6):355-62. PubMed ID: 6620790 [No Abstract] [Full Text] [Related]
31. [Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility]. Mineshita M; Miyazawa T; Doi M; Suei S; Matsuura M; Senoo T; Yamakido M Kekkaku; 1993 Jul; 68(7):479-86. PubMed ID: 8361116 [TBL] [Abstract][Full Text] [Related]
32. [Differentiation of mycobacteria by the results of sensitivity tests for antituberculosis drugs (author's transl)]. Masai H Kekkaku; 1979 May; 54(5):297-302. PubMed ID: 480778 [No Abstract] [Full Text] [Related]
33. [Current treatment of mycobacterioses]. Sauret J; Hernández-Flix S Med Clin (Barc); 1990 Jun; 95(2):64-6. PubMed ID: 2250506 [No Abstract] [Full Text] [Related]
34. [Activity of the ansamycins LM 427 and FCE 22250 on atypical mycobacteria in vitro]. Ungheri D; Morvillo E; Sanfilippo A G Ital Chemioter; 1983; 30(2-3):97-100. PubMed ID: 6329872 [No Abstract] [Full Text] [Related]
35. Drug-resistance in M. tuberculosis and other mycobacteria. David HL Clin Chest Med; 1980 May; 1(2):227-30. PubMed ID: 6794975 [No Abstract] [Full Text] [Related]
36. [Rapidly growing mycobacteria that cause mycobacteriosis in humans]. Lazovskaia AL; Finkel'shteĭn LS Probl Tuberk; 1989; (12):46-50. PubMed ID: 2697879 [TBL] [Abstract][Full Text] [Related]
37. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order]. Makarevich NM; Rudoĭ NM Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726 [No Abstract] [Full Text] [Related]
38. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. Kuze F; Kurasawa T; Bando K; Lee Y; Maekawa N Rev Infect Dis; 1981; 3(5):885-97. PubMed ID: 7339820 [TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of 41 cases of pulmonary atypical mycobacteriosis]. Xia XX Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):200-1, 253. PubMed ID: 1307510 [TBL] [Abstract][Full Text] [Related]
40. [Mycobacterial bases of the therapy of mycobacterioses]. Hejný J Z Erkr Atmungsorgane; 1982; 158(1-2):163-7. PubMed ID: 7072265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]